Clinical Characteristics of 149 Elderly Patients With HG-NHL
| . | G-CSF (77 patients) . | Control (72 patients) . |
|---|---|---|
| Age (yr) | ||
| Median | 69 | 70 |
| Range | 60-82 | 60-80 |
| Sex (male/female) | 35/42 | 34/38 |
| Symptoms (no/yes) | 50/27 | 48/24 |
| Stage (%) | ||
| II | 25 (32) | 25 (35) |
| III | 22 (28) | 18 (25) |
| IV | 30 (40) | 29 (40) |
| Bulky disease (%) | 24 (31) | 18 (25) |
| LDH (>normal) (%) | 30 (38) | 25 (35) |
| Performance status (%) | ||
| 0-1 | 66 (82) | 60 (83) |
| 2 | 11 (18) | 12 (17) |
| Extranodal sites (no/yes) | 49/28 | 45/27 |
| Histology (%) | ||
| Centroblastic | 40 (52) | 35 (49) |
| Immunoblastic | 22 (28.5) | 23 (32) |
| Anaplastic large cell | 5 (6.5) | 4 (5.5) |
| Peripheral T cell | 10 (13) | 10 (13.5) |
| . | G-CSF (77 patients) . | Control (72 patients) . |
|---|---|---|
| Age (yr) | ||
| Median | 69 | 70 |
| Range | 60-82 | 60-80 |
| Sex (male/female) | 35/42 | 34/38 |
| Symptoms (no/yes) | 50/27 | 48/24 |
| Stage (%) | ||
| II | 25 (32) | 25 (35) |
| III | 22 (28) | 18 (25) |
| IV | 30 (40) | 29 (40) |
| Bulky disease (%) | 24 (31) | 18 (25) |
| LDH (>normal) (%) | 30 (38) | 25 (35) |
| Performance status (%) | ||
| 0-1 | 66 (82) | 60 (83) |
| 2 | 11 (18) | 12 (17) |
| Extranodal sites (no/yes) | 49/28 | 45/27 |
| Histology (%) | ||
| Centroblastic | 40 (52) | 35 (49) |
| Immunoblastic | 22 (28.5) | 23 (32) |
| Anaplastic large cell | 5 (6.5) | 4 (5.5) |
| Peripheral T cell | 10 (13) | 10 (13.5) |